Clinical Trial Update: A Study of SA030 Injection in Overweight or Obese Participants [Phase 1]

View source ↗

Summary

Phase 1 trial update for SA030 Injection in overweight or obese participants; the study is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• SA030 Injection (SA030)

Snippet

Sponsor: Suzhou Siran Biotechnology Co.,Ltd. | Conditions: Obese, Overweight | Phase 1 | Status: NOT_YET_RECRUITING